|
SFRS11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.874600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.253600E-01 |
| Normal-vs-Stage2 |
9.246800E-01 |
| Normal-vs-Stage3 |
1.537400E-01 |
| Normal-vs-Stage4 |
9.228600E-01 |
| Stage1-vs-Stage2 |
7.357800E-01 |
| Stage1-vs-Stage3 |
2.625000E-01 |
| Stage1-vs-Stage4 |
8.345400E-01 |
| Stage2-vs-Stage3 |
3.400000E-01 |
| Stage2-vs-Stage4 |
9.716400E-01 |
| Stage3-vs-Stage4 |
5.170800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.976200E-01 |
| Normal-vs-AfricanAmerican |
9.163200E-01 |
| Normal-vs-Asian |
2.830400E-01 |
| Caucasian-vs-AfricanAmerican |
9.008200E-01 |
| Caucasian-vs-Asian |
1.218560E-01 |
| AfricanAmerican-vs-Asian |
1.859830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.392200E-01 |
| Normal-vs-Female |
5.963200E-01 |
| Male-vs-Female |
3.888000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.889600E-01 |
| Normal-vs-Extreme_Weight |
4.845000E-01 |
| Normal-vs-Obese |
9.533400E-01 |
| Normal-vs-Extreme_Obese |
8.607000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.083000E-01 |
| Normal_Weight-vs-Obese |
7.084000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.389200E-01 |
| Extreme_Weight-vs-Obese |
4.419000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.249400E-01 |
| Obese-vs-Extreme_Obese |
8.599200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.896800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.656600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.137600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.891700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.029200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.825760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.647790E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.229800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.448200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.639390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.163400E-01 |
| Normal-VS-Type2 PRCC |
2.594300E-02 |
| Normal-VS-KIRP CIMP |
5.718400E-01 |
| Normal-VS-Unclassified PRCC |
7.208400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.004710E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.875000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.007400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.517800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.323950E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.120600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.060800E-01 |
| Normal-vs-N1 |
6.881600E-01 |
| Normal-vs-N2 |
5.569400E-01 |
| N0-vs-N1 |
1.893020E-01 |
| N0-vs-N2 |
9.193600E-01 |
| N1-vs-N2 |
6.153400E-01 |
|
|
